Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Vet Comp Oncol ; 15(4): 1417-1427, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28217972

ABSTRACT

Canine transitional cell carcinoma (TCC) of the bladder has historically been treated with a combination of chemotherapy, cyclooxygenase inhibitors and radiation therapy. While surgery has been used to treat TCC of the bladder, its efficacy has yet to be established. Thirty-seven client owned dogs that underwent partial cystectomy +/- various nonsurgical treatments for TCC were retrospectively evaluated. The overall median progression-free interval (PFI) was 235 days and the median survival time (ST) was 348 days. Prognostic factors identified on univariate analysis significant for ST were age, tumor location, full thickness excision and frequency of piroxicam administration. Prognostic factors significant for PFI were full thickness excision and frequency of piroxicam administration. The median ST with partial cystectomy and daily piroxicam therapy, with or without chemotherapy, was 772 days. Dogs with non-trigonal bladder TCC treated with full thickness partial cystectomy and daily piroxicam (+/- chemotherapy) may have improved outcome compared to dogs treated with medical therapy.


Subject(s)
Carcinoma, Transitional Cell/veterinary , Cystectomy/veterinary , Dog Diseases/surgery , Urinary Bladder Neoplasms/veterinary , Animals , Carcinoma, Transitional Cell/drug therapy , Carcinoma, Transitional Cell/mortality , Carcinoma, Transitional Cell/surgery , Cyclooxygenase Inhibitors/therapeutic use , Dog Diseases/drug therapy , Dog Diseases/mortality , Dogs , Female , Male , Piroxicam/therapeutic use , Retrospective Studies , Treatment Outcome , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder Neoplasms/mortality , Urinary Bladder Neoplasms/surgery
2.
Hum Reprod ; 30(6): 1365-74, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25908658

ABSTRACT

STUDY QUESTION: What are the experiences of trans persons (i.e. those whose gender identity does not match the gender assigned to them at birth) who sought or accessed assisted reproduction (AR) services in Ontario, Canada, between 2007 and 2010? SUMMARY ANSWER: The majority of trans persons report negative experiences with AR service providers. WHAT IS KNOWN ALREADY: Apart from research examining desire to have children among trans people, most of the literature on this topic has debated the ethics of assisting trans persons to become parents. To-date, all of the published research concerning trans persons' experiences with AR services is solely from the perspective of service providers; no studies have examined the experiences of trans people themselves. STUDY DESIGN, SIZE, DURATION: Secondary qualitative research study of data from nine trans-identified people and their partners (total n = 11) collected as part of a community-based study of access to AR services for sexual and gender minority people between 2010 and 2012. PARTICIPANTS/MATERIALS, SETTING, METHODS: Trans-identified volunteers (and their partners, when applicable) who had used or attempted to access AR services since 2007 from across Ontario, Canada, participated in a 60-90 minute, semi-structured qualitative interview. Qualitative analysis was performed using a descriptive phenomenological approach. Emerging themes were continually checked against the data as part of an iterative process. MAIN RESULTS AND THE ROLE OF CHANCE: The data highlight barriers to accessing AR services for trans people. Participant recommendations for improving AR service provision to better meet the needs of this population are presented. These recommendations address the following areas: (i) AR service provider education and training; (ii) service provider and clinic practices and (iii) clinic environment. LIMITATIONS, REASONS FOR CAUTION: The majority of study participants were trans people who identified as men and who resided in major urban areas; those living in smaller communities may have different experiences that were not adequately captured in this analysis. WIDER IMPLICATIONS OF THE FINDINGS: While existing literature debates the ethics of assisting trans people to become parents through the use of AR, our study demonstrates that they are already accessing or attempting to access these services. This reality necessitates a shift toward exploring the ways in which AR services can be improved to better meet the needs of this population, from the perspectives of both service users and service providers. STUDY FUNDING/COMPETING INTERESTS: This project was supported by the Canadian Institutes of Health Research-Institute of Gender and Health, in partnership with the Assisted Human Reproduction Canada: Catalyst Grant: Psychosocial Issues Associated with Assisted Human Reproduction (FRN-103595). S.M. was supported by a Canada Graduate Scholarship from the Social Science and Humanities Research Council, as well as research funding from Osgoode Hall Law School, York University. S.J.-A. was supported by an Ontario Graduate Scholarship funded by the Province of Ontario and the University of Toronto. TRIAL REGISTRATION NUMBER: N/A.


Subject(s)
Health Services Accessibility , Reproductive Techniques, Assisted/ethics , Transgender Persons/psychology , Adult , Canada , Female , Gender Identity , Humans , Male , Middle Aged
3.
Vet Pathol ; 49(5): 771-4, 2012 Sep.
Article in English | MEDLINE | ID: mdl-21900543

ABSTRACT

Lymphoma in the left femoral nerve of a 10-year-old English Cocker Spaniel caused complete paralysis of the affected limb. Neoplastic cells were immunopositive for CD79a and Pax5 and negative for CD3. Neoplastic cells were in multiple lymph nodes and one kidney but spared bone marrow. The clinical and histologic features in this case resemble those of the rare human condition of neurolymphomatosis.


Subject(s)
Dog Diseases/diagnosis , Femoral Nerve/pathology , Lymphoma, B-Cell/veterinary , Peripheral Nervous System Diseases/veterinary , Animals , CD79 Antigens/immunology , Diagnosis, Differential , Dog Diseases/immunology , Dog Diseases/pathology , Dogs , Extremities/pathology , Fatal Outcome , Female , Femoral Artery/pathology , Immunohistochemistry/veterinary , Immunophenotyping/veterinary , Kidney/pathology , Lymph Nodes/immunology , Lymph Nodes/pathology , Lymphoma, B-Cell/diagnosis , Lymphoma, B-Cell/immunology , Lymphoma, B-Cell/pathology , Neoplastic Cells, Circulating/pathology , PAX5 Transcription Factor/immunology , Paralysis , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/immunology , Peripheral Nervous System Diseases/pathology
4.
Clin Cardiol ; 18(2): 112-4, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7720286

ABSTRACT

A 73-year-old woman presented with acute pulmonary edema and hypotension less than 1 h after taking hydrochlorothiazide 50 mg, a reaction which has been reported as a rare but classic adverse drug response. Though prior cases have supported a noncardiogenic pulmonary edema syndrome, hemodynamic monitoring in this patient demonstrated a refractory low cardiac output state for more than 24 h. In the absence of other etiologies, this represents a new finding.


Subject(s)
Hydrochlorothiazide/adverse effects , Pulmonary Edema/chemically induced , Ventricular Dysfunction/chemically induced , Acute Disease , Aged , Female , Hemodynamics/drug effects , Humans , Hypotension/chemically induced , Pulmonary Edema/physiopathology , Ventricular Dysfunction/physiopathology
5.
Chest ; 90(4): 537-41, 1986 Oct.
Article in English | MEDLINE | ID: mdl-3530647

ABSTRACT

Pulmonary dysfunction commonly follows open heart surgery. To evaluate the effects of positive end-expiratory pressure (PEEP) upon the course and severity of impaired oxygen transfer and roentgenographic evidence of atelectasis after coronary artery bypass grafting (CABG), we randomly assigned 44 patients to positive pressure ventilation and 0, 5, or 10 cm H2O PEEP. Study groups did not differ with respect to preoperative P(A-a)O2 or time on cardiopulmonary bypass. We observed a significant reduction of P(A-a)O2 during positive pressure ventilation with 10 cm H2O PEEP and FIO2 = 0.6 (182 +/- 6 vs 135 +/- 7 mm Hg, p less than .005). Following extubation, P(A-a)O2 measurements of the three groups did not differ when compared 24, 48, 72, 96, or 120 hours after surgery. Roentgenographic atelectasis scores did not differ on the fifth postoperative day. Five days after CABG, P(A-a)O2 exceeded preoperative P(A-a)O2 (29 +/- 1 vs 18 +/- 1 mm Hg, p less than .001), although the roentgenographic distances from hemidiaphragm to lung apex were unchanged (21.2 +/- 0.9 vs 22.0 +/- 0.9 cm). We conclude that routine PEEP improves pulmonary oxygen transfer but, once discontinued, PEEP offers no sustained beneficial effect upon impaired oxygen transfer or roentgenographic evidence of atelectasis following CABG.


Subject(s)
Coronary Artery Bypass/adverse effects , Hypoxia/prevention & control , Positive-Pressure Respiration , Pulmonary Atelectasis/prevention & control , Blood Gas Analysis , Humans , Length of Stay , Lung/diagnostic imaging , Middle Aged , Positive-Pressure Respiration/adverse effects , Pulmonary Atelectasis/diagnostic imaging , Radiography , Random Allocation
SELECTION OF CITATIONS
SEARCH DETAIL
...